DE NICOLA, STELLA

DE NICOLA, STELLA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 18 di 18 (tempo di esecuzione: 0.007 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 1-lug-2018 E. DegasperiR. D'AmbrosioR. PerbelliniS. De NicolaP. Lampertico + Article (author) -
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients 9-lug-2013 A. AghemoE. DegasperiM.G. RumiE. GalmozziL. ValentiR. De FrancescoS. De NicolaC. CheroniM. Colombo + Article (author) -
Effect of the PNPLA3 I148M polymorphism on the outcome of peg-interferon plus ribavirin treatment in chronic hepatitis C 1-ott-2011 L.V.C. ValentiS. De NicolaA.M. AghemoB.M. MottaM. ColomboS.R. Fargion + Article (author) -
Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection 1-ott-2011 A.M. AghemoS. De NicolaM. RumiM. CrimiR.M. SoffrediniS. AbrignaniR. De FrancescoM. Colombo + Article (author) -
HCV-RNA kinetics on-treatment do not predict sustained virologic response in HCV genotype 3 patients receiving sofosbuvir and ribavirin 1-nov-2016 E. DegasperiDE NICOLA, STELLAM. RumiR. D'Ambrosio Article (author) -
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 1-gen-2021 Lombardi A.D'Ambrosio R.Degasperi E.Dibenedetto C.Giorgini A.Pasulo L.Spinelli O.Re T.Rumi M.Aghemo A.Lampertico P.Soffredini R.Perbellini R.Gori A.Colpani M.Manini M.Lazzaroni S.De Nicola S.Angelini Zucchetti T.Rossotti R.Colella E.Magnani C.Mena M.Caramma I.Basilico C.Biagiotti S.Mazzone A.Saladino V.Menzaghi B.Rumi M.Fanetti I.Dibenedetto C.Zermiani P.Zuin M.D'Arminio Monforte A.Capretti A.Messina E.Colombo A. E.Bonfanti P.Conforti S.Menozzi F.Gritti S.Giani P. + Article (author) -
Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosis 1-feb-2012 G. M. PratiA. M. AghemoM. RumiR. D'AmbrosioS. De NicolaE. DegasperiM. Colombo + Article (author) -
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C 29-ago-2014 S. De NicolaP. DongiovanniA. AghemoR. D'AmbrosioL. DonniciS. FargionM. ColomboR. De FrancescoL. Valenti + Article (author) -
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 1-feb-2012 S. De NicolaA. AghemoM. RumiE. GalmozziL. ValentiR. SoffrediniR. De FrancescoG. PratiR. D'AmbrosioM. Colombo + Article (author) -
NPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 1-ott-2010 L. V. C. ValentiM. RumiE. GalmozziA. M. AghemoS. De NicolaP. DongiovanniA. L. FracanzaniR. RamettaM. ColomboS. R. Fargion + Article (author) -
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 1-mar-2011 L.V.C. ValentiM. RumiE. GalmozziA.M. AghemoS. De NicolaP. DongiovanniA.L. FracanzaniR. RamettaM. ColomboS.R. Fargion + Article (author) -
PNPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 1-dic-2010 L. V. C. ValentiM. G. RumiE. GalmozziA. M. AghemoS. De NicolaP. DongiovanniA. L. FracanzaniR. RamettaM. ColomboS. R. Fargion + Article (author) -
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C 1-nov-2012 A.M. AghemoG.M. PratiM. RumiR.M. SoffrediniR. D'AmbrosioE. OrsiS. De NicolaE. DegasperiV. GranciniM. Colombo Article (author) -
Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritis 1-gen-2014 S. De NicolaA. AghemoR. D'AmbrosioM.G. RumiP. MessaM. Colombo + Article (author) -
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent 25-apr-2014 R. D'AmbrosioA. AghemoR. De FrancescoM.G. RumiE. GalmozziS. De NicolaC. CheroniP. LamperticoM. Colombo + Article (author) -
The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy 1-gen-2011 R. D'AmbrosioM. RumiA. Dell' EraP. LamperticoS. De NicolaG. M. PratiR. de FranchisM. Colombo + Article (author) -
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 1-lug-2015 M. MilanoA. AghemoP. DongiovanniS. De NicolaA.L. FracanzaniR. D'AmbrosioR. De FrancescoS. FargionM. ColomboL. Valenti + Article (author) -
Twelve-week post-treatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapy 1-gen-2010 M.G. RumiS. De NicolaM. Colombo + Article (author) -